


You want to sell herbal products in the U.S. without headaches. Fair. This guide walks you through the real rules that matter day one—DSHEA, labeling, claims, NDI, Part 111 cGMP, adverse events, plus advertising. I’ll keep it plain, practical, and rooted in how a plant-based SKU actually moves from sourcing to label to shelf. I’ll also show where GuoCao fits to lower friction on specs, documentation, and OEM/ODM scale-up.
The five must-haves on label
Put them on the retail container. Keep typography and placement compliant. No guesswork.
Identity and naming
Use common name and Latin binomial when you can. Match your COA and spec. If the product uses an extract, disclose that in the panel, not buried in prose.
Botanicals are special. In the Supplement Facts line item, show the part of plant: root, leaf, seed, bark, flower, whole herb, etc. Example:
Turmeric (Curcuma longa) — root extract … 500 mg
Standardized to curcuminoids 95%
Other ingredients: Hypromellose (capsule), rice flour.
Keep the serving size, amount per serving, any standardization, and %DV (if applicable) aligned to 21 CFR 101.36 formatting logic. If you list a proprietary blend, disclose total weight and the components in descending order.
Traceability hack
Make plant part obvious at sourcing. GuoCao’s categories already map by morphology, which simplifies label drafting and receiving checks:
(Internal links only. No external links in this piece.)

You can say “supports immune health” or “helps maintain joint comfort.” You can’t say “treats arthritis” or “prevents influenza.” Those are disease claims and push you into drug land.
Two actions for every structure/function claim:
Team workflow that actually works
If your botanical wasn’t on the market as a food or supplement before Oct 15, 1994, or it has been chemically altered (think novel solvent, atypical extract ratio, enriched fraction), you likely have a New Dietary Ingredient.
What that means
You submit an NDI Notification to FDA at least 75 days before interstate marketing. The core of that file: identity, manufacturing, composition, specifications, proposed use, daily intake, and safety evidence (tox, human, history of use). No shortcuts here.
Fast triage for your portfolio
Why loop GuoCao in early
We can support composition narratives and method details that make your dossier tighter. Our third-party COA capability (heavy metals, pesticide residues, micro), plus clear spec sheets and lot genealogy, helps your safety argument land clean.
Part 111 is the operating system for your plant and your partners. It covers manufacturing, packaging, labeling, and holding of dietary supplements.
Core documents you need ready on day one
Botanical realities
Subpart M expects you to protect quality during storage and distribution. Document conditions (ambient, cool, moisture control), packaging integrity, and transportation practices. GuoCao runs ambient/cool/atmosphere-controlled warehouses, which line up with Subpart M expectations. That makes your downstream hold-and-release faster and calmer.

You must list a U.S. address or phone on the label for consumers to report adverse events. If a serious adverse event occurs and reaches your “responsible person,” submit to FDA no later than 15 business days. Keep records and send follow-ups as new information arrives.
Practical build
Labels are FDA. Advertising is FTC. Health-related claims in ads must be truthful, not misleading, and backed by competent and reliable scientific evidence. Human data wins. Qualify limitations clearly and conspicuously. No micro-font magic.
Daily habit
If your copy says the herb treats, prevents, or cures a disease, that’s a drug claim. Then you’re on the botanical drug path (IND/NDA). Most supplement brands don’t want that. So keep your language in the structure/function lane, and keep your evidence file tight for that scope.
Why sourcing structure matters
The fastest way to blow a label is to lose the plant part or mismatch Latin binomial. Start at intake with materials labeled by part and origin. GuoCao’s catalog layout helps you do that without thinking:
Factory and QA backbone
GuoCao operates GMP herbal slice production lines with ISO 22000 food safety management. We maintain ambient/cool/MAP warehousing, support third-party COA testing, and keep retain samples for traceability. Annual capacity reaches 2,500 tons. OEM/ODM and functional beverage fermentation are live. Products ship to 30+ countries and regions—U.S., EU, Australia, Japan, Korea, Canada, Southeast Asia—serving supplement brands, beverage formulators, hospitals, cosmetic raw buyers, and distributors.
What that means for your file room
| Step | What to include | Pass/Fail rule | Records |
|---|---|---|---|
| Product identity | “Dietary Supplement” on PDP; common + Latin name | No disease terms on PDP | Final artwork, legal sign-off |
| Supplement Facts | Plant part shown; serving size; extract info; %DV (if any) | 101.36 format rules followed | Label spec, proof, printer check |
| Claims | Structure/function only; DSHEA disclaimer; 30-day notice | Notification sent after first marketing | Claims matrix, substantiation, notice copy |
| NDI screen | Pre-DSHEA vs. chemically altered decision | If NDI → ≥75-day premarket notification | NDIN packet or exemption memo |
| cGMP 111 | MMR, BPR, QC release, retain samples, stability | Deviations closed with CAPA | SOPs, BPRs, release logs, CAPA |
| Subpart M | Storage/transport conditions defined | Packaging protects quality | Warehouse logs, carrier SOPs |
| AER | 15-day serious event reporting pathway | U.S. address/phone on label | AER log, MedWatch records |
| Advertising | Competent and reliable evidence for claims | Disclosures clear and conspicuous | Evidence library, approvals |

| Claim type | Premarket review? | Notes |
|---|---|---|
| Structure/Function (“supports liver health”) | No pre-approval; 30-day FDA notification post-marketing; DSHEA disclaimer | Keep substantiation aligned to labeled use |
| Dietary Guidance (“use as part of a balanced routine”) | No pre-approval | Avoid implying disease mitigation |
| Health Claim (substance–disease) | FDA-authorized/qualified | High evidence bar; rarely used for botanicals |
| Disease Claim (“treats hypertension”) | Drug pathway (IND/NDA) | Outside supplement scope |
GuoCao can support each step—from category-clean sourcing (Roots & Rhizomes, Fruits & Seeds, Flowers & Whole Herbs, Barks) to OEM/ODM builds (Custom Solutions) with ISO 22000 and third-party COA ready. That means fewer surprises when QA opens the file cabinet.